Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX009 (ip) |
mean survival time |
saline |
50.0 mg/kg/injection |
88.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
mean survival time |
saline |
100.0 mg/kg/injection |
86.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
mean survival time |
saline |
200.0 mg/kg/injection |
86.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
mean survival time |
saline with Tween-80 |
50.0 mg/kg/injection |
102.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
mean survival time |
saline with Tween-80 |
100.0 mg/kg/injection |
92.0 |
Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
mean survival time |
saline with Tween-80 |
200.0 mg/kg/injection |
96.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q04DX003 (ip) |
mean survival time |
saline |
100.0 mg/kg/injection |
90.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q04DX003 (ip) |
mean survival time |
saline |
200.0 mg/kg/injection |
93.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q04DX003 (ip) |
mean survival time |
saline |
400.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |